Mostrar el registro sencillo del ítem

Artículo

dc.creatorSánchez Fidalgo, Susanaes
dc.creatorGuzmán-Ramos, Maria Isabeles
dc.creatorGalván Banqueri, Mercedeses
dc.creatorBernabeu Wittel, Máximoes
dc.creatorSantos-Ramos, Bernardoes
dc.date.accessioned2024-02-27T18:31:11Z
dc.date.available2024-02-27T18:31:11Z
dc.date.issued2017
dc.identifier.citationSánchez Fidalgo, S., Guzmán-Ramos, M.I., Galván Banqueri, M., Bernabeu Wittel, M. y Santos-Ramos, B. (2017). Prevalence of drug interactions in elderly patients with multimorbidity in primary care. International Journal of Clinical Pharmacy, 39 (2), 343-353. https://doi.org/10.1007/s11096-017-0439-1.
dc.identifier.issn2210-7703es
dc.identifier.issn2210-7711es
dc.identifier.urihttps://hdl.handle.net/11441/155678
dc.description.abstractBackground Drug interactions (DIs) are a significant cause of medicationrelated problems. The aging population, high chronic diseases prevalence and polypharmacy are closely associated factors. Aim of the review To study the prevalence, types and associated factors of DIs in multimorbidity patients of over 65 years of age in primary care. Methods Relevant studies on DI prevalence in this population were reviewed in PubMed, Cochrane Library and EMBASE (January 2000–December 2015). Independent variables (duration, target population, age, sex, mean of drugs and diseases, geographical localization, DI databases used and study designs) and dependent variables (prevalence, number of DIs per 100 patients and per patient, number of clinicallyrelevant DIs per 100 patients, most common DI and associated factors) were classified for each article. Results The search generated 749 articles and 46 duplicates were discarded. After reviewing, 10 articles were included. Seven studies were observational and 3 were quasiexperimental. Seven out of 10 used interaction databases. Only 2 studies described both actual and potential DIs. The prevalence of multimorbidity patients with DI ranged from 25.1 to 100% and the number of DIs per 100 patients was from 30 to 388.3. All the lower values correspond to the study conducted at the nursing home. This could be due to special care offered in these centres, where the medication is more controlled. The most frequent DIs were reported in five articles. However, these results could not be correlated since they were ranked using different methodologies. ACEIs, diuretics and NSAID were the most common therapeutic groups. Finally, 5 studies identified factors associated with the presence of potential DIs. The number of drugs and age were the most significant factors. Conclusions There is little evidence of prevalence of actual and potential DIs in elderly patients with multimorbidity in outpatient settings, showing widely heterogeneous results.es
dc.formatapplication/pdfes
dc.format.extent11 p.es
dc.language.isoenges
dc.publisherSpringer Naturees
dc.relation.ispartofInternational Journal of Clinical Pharmacy, 39 (2), 343-353.
dc.subjectAgedes
dc.subjectDrug interactiones
dc.subjectOutpatientses
dc.subjectPatients with multimorbidityes
dc.subjectPrevalencees
dc.titlePrevalence of drug interactions in elderly patients with multimorbidity in primary carees
dc.typeinfo:eu-repo/semantics/articlees
dc.type.versioninfo:eu-repo/semantics/acceptedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Medicina Preventiva y Salud Públicaes
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Medicinaes
dc.date.embargoEndDate2018-02
dc.relation.publisherversionhttps://link.springer.com/article/10.1007/s11096-017-0439-1es
dc.identifier.doi10.1007/s11096-017-0439-1es
dc.journaltitleInternational Journal of Clinical Pharmacyes
dc.publication.volumen39es
dc.publication.issue2es
dc.publication.initialPage343es
dc.publication.endPage353es

FicherosTamañoFormatoVerDescripción
Prevalence of drug.pdf685.7KbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Este documento está protegido por los derechos de propiedad intelectual e industrial. Sin perjuicio de las exenciones legales existentes, queda prohibida su reproducción, distribución, comunicación pública o transformación sin la autorización del titular de los derechos, a menos que se indique lo contrario.